Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

NCT04774822 · clinicaltrials.gov ↗

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy
Diabetic Eye Problems
Diabetic Macular Edema

Interventions

PROCEDURE: Color Fundus Photography
DRUG: Mydriatics Agent
PROCEDURE: Optical Coherence Tomography (OCT)

Sponsor

RETINA-AI Health, Inc.